Prof Walter Weder speaks to ecancer at BGICC 2023 about the role of multidisciplinary tumour board in managing stage 3 lung cancer.

He explains that the multidisciplinary tumour board gives recommendations that are unique for that specific tumour board and this may differ between institutions. The decision reached depends on the institutional experience, guidelines and new data which are all integrated.

Prof Weder also outlines the differences in treatment guidance between resectable and unresectable stage 3 lung cancer.

свернуть